These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 17706966)
1. White matter inhibitors in CNS axon regeneration failure. Xie F; Zheng B Exp Neurol; 2008 Feb; 209(2):302-12. PubMed ID: 17706966 [TBL] [Abstract][Full Text] [Related]
2. Receptors for myelin inhibitors: Structures and therapeutic opportunities. Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659 [TBL] [Abstract][Full Text] [Related]
3. [Inhibitory proteins against axon regeneration in the central nervous system]. Hu JG; Lu PH; Xu XM Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207 [TBL] [Abstract][Full Text] [Related]
4. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. Hunt D; Coffin RS; Anderson PN J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233 [TBL] [Abstract][Full Text] [Related]
5. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. Winzeler AM; Mandemakers WJ; Sun MZ; Stafford M; Phillips CT; Barres BA J Neurosci; 2011 Apr; 31(17):6481-92. PubMed ID: 21525289 [TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism and regulation of axon growth inhibition]. Yamashita T Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484 [TBL] [Abstract][Full Text] [Related]
7. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310 [TBL] [Abstract][Full Text] [Related]
14. Molecular approaches to spinal cord repair. David S; Lacroix S Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698 [TBL] [Abstract][Full Text] [Related]
15. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Sandvig A; Berry M; Barrett LB; Butt A; Logan A Glia; 2004 May; 46(3):225-51. PubMed ID: 15048847 [TBL] [Abstract][Full Text] [Related]
16. Nogo and axon regeneration. Schwab ME Curr Opin Neurobiol; 2004 Feb; 14(1):118-24. PubMed ID: 15018947 [TBL] [Abstract][Full Text] [Related]
17. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Lee JK; Geoffroy CG; Chan AF; Tolentino KE; Crawford MJ; Leal MA; Kang B; Zheng B Neuron; 2010 Jun; 66(5):663-70. PubMed ID: 20547125 [TBL] [Abstract][Full Text] [Related]
18. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo. Peterson SL; Nguyen HX; Mendez OA; Anderson AJ J Neurosci; 2015 Mar; 35(10):4332-49. PubMed ID: 25762679 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Buchli AD; Schwab ME Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758 [TBL] [Abstract][Full Text] [Related]